Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: A phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG)

Michael Crump; Tara Baetz; Stephen Couban; Andrew Belch; Deborah Marcellus; Kang Howson-Jan; Kevin Imrie; Robert Myers; Grenfell Adams; Keyue Ding; Nancy Paul; Lois Shepherd; Jose Iglesias; Ralph Meyer

doi:10.1002/cncr.20587

Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: A phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG)

Michael Crump, Tara Baetz, Stephen Couban, Andrew Belch, Deborah Marcellus, Kang Howson-Jan, Kevin Imrie, Robert Myers, Grenfell Adams, Keyue Ding, Nancy Paul, Lois Shepherd, Jose Iglesias, Ralph Meyer

科研成果: 期刊稿件 › 文章 › 同行评审

121 引用（Scopus）

源语言	英语
页（从-至）	1835-1842
页数	8
期刊	Cancer
卷	101
期	8
DOI	https://doi.org/10.1002/cncr.20587
出版状态	已出版 - 10月 15 2004
已对外发布	是

!!!ASJC Scopus Subject Areas

肿瘤学
癌症研究

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1002/cncr.20587

其它文件与链接

指纹

探究 'Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: A phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG)' 的科研主题。它们共同构成独一无二的指纹。

引用此

Crump, M., Baetz, T., Couban, S., Belch, A., Marcellus, D., Howson-Jan, K., Imrie, K., Myers, R., Adams, G., Ding, K., Paul, N., Shepherd, L., Iglesias, J., & Meyer, R. (2004). Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: A phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG). Cancer, 101(8), 1835-1842. https://doi.org/10.1002/cncr.20587

Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: A phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG). / Crump, Michael; Baetz, Tara; Couban, Stephen 等.
在: Cancer, 卷 101, 号码 8, 15.10.2004, 页码 1835-1842.

科研成果: 期刊稿件 › 文章 › 同行评审

Crump, M, Baetz, T, Couban, S, Belch, A, Marcellus, D, Howson-Jan, K, Imrie, K, Myers, R, Adams, G, Ding, K, Paul, N, Shepherd, L, Iglesias, J & Meyer, R 2004, 'Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: A phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG)', Cancer, 卷 101, 号码 8, 页码 1835-1842. https://doi.org/10.1002/cncr.20587

@article{54f9d62cef254f77b3dea7ac8515335a,

title = "Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: A phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG)",

author = "Michael Crump and Tara Baetz and Stephen Couban and Andrew Belch and Deborah Marcellus and Kang Howson-Jan and Kevin Imrie and Robert Myers and Grenfell Adams and Keyue Ding and Nancy Paul and Lois Shepherd and Jose Iglesias and Ralph Meyer",

year = "2004",

month = oct,

day = "15",

doi = "10.1002/cncr.20587",

language = "English",

volume = "101",

pages = "1835--1842",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "8",

}

TY - JOUR

T1 - Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma

T2 - A phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG)

AU - Crump, Michael

AU - Baetz, Tara

AU - Couban, Stephen

AU - Belch, Andrew

AU - Marcellus, Deborah

AU - Howson-Jan, Kang

AU - Imrie, Kevin

AU - Myers, Robert

AU - Adams, Grenfell

AU - Ding, Keyue

AU - Paul, Nancy

AU - Shepherd, Lois

AU - Iglesias, Jose

AU - Meyer, Ralph

PY - 2004/10/15

Y1 - 2004/10/15

UR - http://www.scopus.com/inward/record.url?scp=4744361815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4744361815&partnerID=8YFLogxK

U2 - 10.1002/cncr.20587

DO - 10.1002/cncr.20587

M3 - Article

C2 - 15386331

AN - SCOPUS:4744361815

SN - 0008-543X

VL - 101

SP - 1835

EP - 1842

JO - Cancer

JF - Cancer

IS - 8

ER -